glp-1 medications market 2025 Pharma Giants Bet on Next-Generation Treatments to Sustain Growth How to Invest in GLP-1
Description
This waned slightly to 69.4% at 180 days
doi: 10.1111/andr.12099
Long SJ, Ja Sutton, Amaee WB, Giouvanoudi A, Spyrou NM, Rogers PJ et al
Although it is challenging to develop individualized therapeutic regimens, personalized medicine, such as genetics and biomarker testing, can be used to tailor therapies to patients specific conditions, thereby improving the safety and efficacy of treatments (Sugandh et al., 2023)
GLP-1, or glucagon-like peptide-1, is a hormone produced in the intestines in response to food intake
They will do it by understanding the emotional and behavioral reality of this customer and designing moments of recognition, guidance, and support into the experience at every touchpoint
